A Case–Control Study of Erectile Dysfunction Among Men Diagnosed with Panic Disorder

Total Page:16

File Type:pdf, Size:1020Kb

A Case–Control Study of Erectile Dysfunction Among Men Diagnosed with Panic Disorder International Journal of Impotence Research (2004) 16, 299–302 & 2004 Nature Publishing Group All rights reserved 0955-9930/04 $30.00 www.nature.com/ijir Case Report A case–control study of erectile dysfunction among men diagnosed with panic disorder WA Blumentals1*, A Gomez-Caminero1,*, RR Brown1, V Vannappagari2 and LJ Russo1 1Worldwide Epidemiology, GlaxoSmithKline Pharmaceuticals, Collegeville, Pennsylvania, USA; and 2Department of Epidemiology, University of North Carolina at Chapel Hill, McGavran-Greenberg Hall, Chapel Hill, North Carolina, USA The association between panic disorder and erectile dysfunction (ED) among men was examined in the Integrated Healthcare Information Services National Managed Care Benchmark Database (IHCIS). The IHCIS is a fully de-identified, HIPAA compliant database and includes complete medical history for more than 17 million managed care lives; data from more than 30 US health plans, covering seven census regions; and patient demographics, including morbidity, age and gender. A total of 60 949 ED cases and 243 796 controls were included for analysis. Unconditional logistic regression analyses were first performed to assess the crude risk of ED, and adjusted risks of ED that accounted for comorbid conditions and comedications. A second set of analyses measured the crude and adjusted risks after restricting the patient population to men who were diagnosed with panic disorder at least 1 month prior to an ED diagnosis. In the first set of analyses, men with panic disorder were observed to have more than a two-fold increase in risk for ED (OR ¼ 2.29, 95% CI ¼ 2.03, 2.58). After adjusting for comorbid conditions, a 52% increase in risk of ED was observed (OR ¼ 1.52, 95% CI ¼ 1.34, 1.72). Following subsequent adjustment for comorbidities and comedications, a 33% increased risk of ED was detected (OR ¼ 1.33, 95% CI ¼ 1.17, 1.51). In the second set of analyses studying panic disorder that preceded ED, only a 13% higher risk was noted (OR ¼ 1.13, 95% CI ¼ 0.97, 1.31). However, after adjusting for comorbid conditions, a 25% reduction in risk was observed (OR ¼ 0.75, 95% CI ¼ 0.64, 0.88). A 35% risk reduction was seen after adjusting for comorbidities and comedications (OR ¼ 0.65, 95% CI ¼ 0.56, 0.77). International Journal of Impotence Research (2004) 16, 299–302. doi:10.1038/sj.ijir.3901147 Introduction in the development and maintenance of sexual dysfunction.1 Kaplan3 found a high prevalence of panic disorder Approximately 5–20% of men are estimated to have among patients with active sexual aversion, but the moderate–to-severe erectile dysfunction (ED) and up study did not look into the association between ED 1 to 70% of them are not treated. The prevalence of and panic disorder. Sbrocco et al,4 in their case ED also varies depending on the age of study report involving three men with panic disorder participants, from 2 to 9% in men younger than and ED hypothesized that there is a significant over- 40 y; 10–71% among men older than 70 y to 18–86% lap between panic disorder symptoms and sexual 2 among men older than 86 y. Variability in the arousal sensations, which may lead to sexual prevalence of ED may reflect differences in defini- avoidance in patients with panic disorder. In their 1,2 tions, methodology, and study populations. assessment of 35 patients with erectile difficulties The long-standing psychological assumption is they found that three patients also had panic that anxiety and sexual arousal are mutually disorder. For these three cases, retrospective reports inhibitive and that chronic anxiety is important indicated that the erectile problems were preceded by panic attacks. Nevertheless, these were case reports and thus can be viewed as a preliminary study requiring additional research. 5 *Correspondence: WA Blumentals, PhD, 5421 Balsam Figueira et al retrospectively assessed the sexual Place, #203 Mason, OH 45040, USA. function and sexual history of 30 patients with E-mail: [email protected] social phobia and 28 patients with panic disorder. Received 16 June 2003; revised 9 August 2003; accepted 8 A semistructured interview was used to make the September 2003 diagnosis of panic disorder and social phobia. Panic disorder and ED WA Blumentals et al 300 Participants were interviewed to collect informa- tics, psychotropics, central nervous system depres- tion on sexual history. Panic disorder patients sants, and narcotic analgesics; benign prostatic reported a significantly higher number of sexual hyperplasia, prostate cancer, hypertension, depres- disorders as compared to social phobia participants sion, diabetes, diabetic neuropathy, hyperlipidemia, (21/28 vs 10/30). Sexual aversion disorder was most multiple sclerosis, Parkinson’s disease, spinal cord frequently found in panic disorder patients (12/28) injury, and renal failure. Among men diagnosed and premature ejaculation was most common in the with panic disorder, those patients with the follow- social phobia group (9/19). Out of the 14 male ing were excluded: acute stress reaction, transient patients with panic disorder and sexual disorders, adjustment reaction, neurasthenia, psychophysiolo- one reported ED. The study had a small sample size, gical disorders, and separation anxiety. These con- the problem of recall bias, and only one patient with ditions could potentially exacerbate the true both panic disorder and ED. Hence, it is difficult to association between panic disorder and ED. draw any conclusions about the relationship between 6 the two. Okulate et al studied the prevalence and Analysis predictors of ED among 829 Nigerian military men ranging in age from 18 to 69 y. ED was assessed using the International Index of Erectile Function Ques- All risk analyses were performed utilizing uncondi- tionnaire; and the Patient Health Questionnaire was tional logistic regression models with SASs statis- used to screen for depression, alcohol abuse, and tical software. Two sets of analyses were performed. panic disorder (based on DSM-IV criteria). A total of The first set did not consider when panic disorder 329 out of 829 men (40%) had ED, and 10/829 (1%) was diagnosed in relation to the ED diagnosis date, had panic disorder. Of the 329 men with ED, two had and the second set of analyses was restricted to men panic disorder. Multivariate analysis indicated that with a diagnosis of panic disorder at least 1 month panic disorder was not a predictor of ED. However, before a diagnosis of ED. In both sets of analyses, since only two men experienced panic disorder and crude and adjusted odds ratios were computed. ED, no conclusions can be reached from this analysis. The adjusted odds ratios were based on models This study seeks to better understand the magni- that adjusted for all likely disease comorbidities; tude of association between panic disorder and ED and subsequently, comorbidities and comedications. and attempts to elucidate any causal link that may exist between the two disorders. Results Materials and methods As seen in Table 1, the mean age of cases in the first set of analyses was 51.6 y compared to a mean age of A case–control study was conducted to assess the relationship between panic disorder and ED among patients observed in the Integrated Healthcare Table 1 Descriptive characteristics of the cases and controls— Information Services National Managed Care Bench- first set of analyses mark Database (IHCIS) from January 1, 1997 through Study population Cases Controls March 31, 2002.. (n ¼ 304 745) (n ¼ 60 949) (n ¼ 243 796) Cases Age at ED diagnosis Mean age in y (s.d.) 51.6 (11.5) 56.6 (11.4) Panic disorder 427 (0.7%) 750 (0.3%) A total of 427 patients with panic disorder and ED Cigarette smokers 2076 (3.4%) 4751 (1.9%) were identified based on ICD-9 diagnosis codes in Prostate cancer 4014 (6.6%) 9013 (3.7%) Hypertension 23 316 (38.3%) 89 928 (36.9%) the IHCIS, of which only 210 had the panic disorder Depression 2235 (3.7%) 4113 (1.7%) diagnosis at least 1 month prior to the ED diagnosis. Diabetes 11 190 (18.4%) 34 194 (14.0%) Diabetic neuropathy 1509 (2.5%) 3301 (1.4%) Hyperlipidemia 24 026 (39.4%) 82 781 (34.0%) Controls Multiple sclerosis 288 (0.5%) 544 (0.2%) Parkinson’s disease 215 (0.4%) 1138 (0.5%) Spinal cord injury 703 (1.2%) 2297 (0.9%) Controls. were matched to cases using a 5-y window Renal failure 813 (1.3%) 3530 (1.4%) on age, where the age of a case was determined at ED Diuretic users 5578 (9.2%) 22 326 (9.2%) diagnosis date. Four times the number of cases were Psychotropic users 8718 (14.3%) 23 073 (9.5%) Central nervous system 74 (0.1%) 298 (0.1%) selected, and thus 243 796 controls were included depressant users for analyses. Narcotic analgesic users 16 567 (27.2%) 44 600 (18.3%) Potential confounding variables included age at ED diagnosis; cigarette smoking; ever use of diure- s.d. ¼ standard deviation. International Journal of Impotence Research Panic disorder and ED WA Blumentals et al 301 Table 2 Association between panic disorder and ED—first set of Table 3 Descriptive characteristics of the cases and controls— analysesa second set of analyses Association OR (95% CI) Study population Cases Controls (n ¼ 304 518) (n ¼ 60 722) (n ¼ 243 796) Model 1: Panic disorder and ED (crude) 2.29 (2.03, 2.58) Model 2: Panic disorder and ED (adjusted 1.52 (1.34, 1.72) Age at ED diagnosis for disease risk factors) Mean age in y (s.d.) 51.6 (11.5) 56.6 (11.4) Model 3: Panic disorder and ED (adjusted 1.33 (1.17, 1.51) Panic disorder 210 (0.3%) 750 (0.3%) for disease risk factors and medications) Cigarette smokers 2063 (3.4%) 4751 (1.9%) Prostate cancer 3991 (6.6%) 9013 (3.7%) a Model 2 is adjusted for: age at ED index date, cigarette smoking, Hypertension 23 217 (38.2%) 89 928 (36.9%) Depression 2172 (3.6%) 4113 (1.7%) benign prostatic hyperplasia, prostate cancer, hypertension, Diabetes 11 162 (18.4%) 34 194 (14.0%) depression, diabetes, diabetic neuropathy, hyperlipidemia, multi- ple sclerosis, Parkinson’s disease, spinal cord injury, and renal Diabetic neuropathy 1505 (2.5%) 3301 (1.4%) failure.
Recommended publications
  • Neurasthenia in a Longitudinal Cohort Study of Young Adults
    Psychological Medicine, 1994, 24, 1013-1024. Copyright © 1994 Cambridge University Press Neurasthenia in a longitudinal cohort study of young adults K. MERIKANGAS1 AND J. ANGST From the Genetic Epidemiology Research Unit, Yale University School of Medicine, New Haven, CT, USA; and Psychiatric University Hospital, Zurich, Switzerland SYNOPSIS This study examines the concept of neurasthenia in a longitudinal cohort of young adults selected from a community sample of the canton of Zurich, Switzerland. The major focus is on the validity of the case definition of neurasthenia. Close approximations of the proposed descriptive and research definitions of the ICD-10 are employed as well as the concept of'irritable weakness' as described in 1831 by Kraus (1926-1932). The prevalence of neurasthenia defined according to the ICD-10 criteria was: 1 % across 10 years and 0-9% in 1988 for a duration criterion of ^ 3 months; and 81 % across 10 years and 12% in 1988 for a duration criterion of ^ 1 month. The duration criterion of ^ 3 months appeared to be excessively restrictive to represent individuals with neurasthenia in the community. Subjects with 1 month episodes of neurasthenia exhibited sufficient differences from controls and similarities to subjects with anxiety or depressive disorders to justify a 1 month duration criterion for neurasthenia in community samples. The clinical significance of neurasthenia was indicated by the magnitude of subjective distress, and occupational and social impairment reported by the majority of the cases. Prospective assessment of the longitudinal course of neurasthenia revealed that approximately 50 % of the cases continued to exhibit this disorder at follow-up.
    [Show full text]
  • Evidence Report: Risk of Adverse Cognitive Or Behavioral Conditions
    Evidence Report: Risk of Adverse Cognitive or Behavioral Conditions and Psychiatric Disorders Human Research Program Behavioral Health and Performance Approved for Public Release: April 11, 2016 National Aeronautics and Space Administration Lyndon B. Johnson Space Center Houston, Texas 1 CURRENT CONTRIBUTING AUTHORS: Kelley J. Slack, Ph.D. Wyle Science Technology & Engineering Thomas J. Williams, Ph.D. Wyle Science Technology & Engineering Jason S. Schneiderman, Ph.D. Wyle Science Technology & Engineering Alexandra M. Whitmire, Ph.D. Wyle Science Technology & Engineering James J. Picano, Ph.D. Universities Space Research Association PREVIOUS CONTRIBUTING AUTHORS: Lauren B. Leveton, Ph.D. NASA Johnson Space Center Lacey L. Schmidt, Ph.D. Minerva Work Solutions Camille Shea, Ph.D. Houston Police Department 2 TABLE OF CONTENTS I. PRD RISK TITLE: RISK OF ADVERSE COGNITIVE OR BEHAVIORAL CONDITIONS AND PSYCHIATRIC DISORDERS ............................................................................................. 6 II. EXECUTIVE SUMMARY .................................................................................................... 9 III. INTRODUCTION ................................................................................................................ 11 IV. EVIDENCE ........................................................................................................................... 14 A. Space Flight Evidence .................................................................................................... 17 1. Sources
    [Show full text]
  • Neurology A.N
    Postgrad Med J (1991) 67, 509 - 531 i) The Fellowship of Postgraduate Medicine, 1991 Postgrad Med J: first published as 10.1136/pgmj.67.788.509 on 1 June 1991. Downloaded from Reviews in Medicine Neurology A.N. Gale, J.M. Gibbs, A.H.V. Schapira and P.K. Thomas Department ofNeurological Science, Royal Free Hospital School ofMedicine, RowlandHill Street, London NW3 2PF, UK Introduction The past few years have seen a significant improve- gitis, Tunkel et al.' point out that the mortality has ment in our ability to diagnose and treat neuro- not changed significantly over the last 30 years but logical diseases. New imaging techniques such as the prognosis for Gram-negative meningitis has computed tomographic (CT) scanning and magne- been markedly improved by the introduction of tic resonance imaging (MRI) have had a major third generation cephalosporins. impact on the practice ofneurology. Whilst techni- In adults and older children the commonest ques such as positron emission tomography (PET) causative organisms are Neisseria meningitidis and are mainly research orientated at present, they may Streptococcus pneumoniae and the treatment of soon find wider clinical application. New electro- choice in the UK is intravenous benzyl penicillin, physiological examinations such as magnetic brain with chloramphenicol as a second line agent. In stimulation have found use in the investigation of children aged 4 months to 6 years the most likely central motor conduction pathways. The applica- organism is Haemophilus influenzae type b which copyright. tion of the techniques of molecular biology to the may be resistant to ampicillin. Initial treatment in study of neurological disease is having a profound this age group has been chloramphenicol and effect on our understanding of the mechanisms ampicillin until sensitivities are known, but Peltona underlying these diseases.
    [Show full text]
  • The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic Criteria for Research
    The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic criteria for research World Health Organization Geneva The World Health Organization is a specialized agency of the United Nations with primary responsibility for international health matters and public health. Through this organization, which was created in 1948, the health professions of some 180 countries exchange their knowledge and experience with the aim of making possible the attainment by all citizens of the world by the year 2000 of a level of health that will permit them to lead a socially and economically productive life. By means of direct technical cooperation with its Member States, and by stimulating such cooperation among them, WHO promotes the development of comprehensive health services, the prevention and control of diseases, the improvement of environmental conditions, the development of human resources for health, the coordination and development of biomedical and health services research, and the planning and implementation of health programmes. These broad fields of endeavour encompass a wide variety of activities, such as developing systems of primary health care that reach the whole population of Member countries; promoting the health of mothers and children; combating malnutrition; controlling malaria and other communicable diseases including tuberculosis and leprosy; coordinating the global strategy for the prevention and control of AIDS; having achieved the eradication of smallpox, promoting mass immunization against a number of other
    [Show full text]
  • Reviving the Diagnosis of Neurasthenia"
    Psychological Medicine, 1997, 27, 989–994. Printed in the United Kingdom # 1997 Cambridge University Press EDITORIAL Reviving the diagnosis of neurasthenia" ‘Whether or not it is worthwhile to distinguish between ‘‘neurasthenia’’ and ‘‘dysthymic disorders’’ must depend either on the demonstration that such syndromes have different social covariates, or pursue a different course, or have particular responses to treatment. Until such studies are forthcoming, the distinction seems especially insubstantial.’ (Goldberg & Bridges, 1991) Epidemiological studies now indicate that fatigue is one of the most common symptoms of ill-health in the community, primary care and other medical settings, and that syndromal diagnoses based on fatigue (including chronic fatigue and neurasthenia) are prevalent and major sources of health care utilization. Such syndromes are characterized by a combination of persistent and disabling fatigue and neuropsychological and neuromuscular symptoms (Lloyd et al. 1990; Angst & Koch, 1991; Sharpe et al. 1991; Fukuda et al. 1994). Essentially, the differences between these syndromes reflect variations in duration criteria rather than symptom constructs. Specifically, the Centers for Disease Control (CDC) defines ‘prolonged fatigue’ as a syndrome of at least 1 month’s duration, and chronic fatigue (including idiopathic and chronic fatigue syndrome – CFS) as a fatigue syndrome of at least 6 months duration (Fukuda et al. 1994). The ICD-10 classification system (World Health Organization, 1992) now includes a formal diagnosis of neurasthenia (F48.0) based on mental and physical fatigue of at least 3 months duration. Despite the current international and epidemiological interest in these disorders, DSM-IV has simply included them within the ‘Undifferentiated Somatoform Disorders – 300.81’ category (American Psychiatric Association, 1994).
    [Show full text]
  • Fatigue Syndrome: Neurasthenia Revived
    result in uneven steering.9 If the tyres are deflated or 9 Goodwill CJ. Wheelchairs. In: Goodwill Cj, Chamberlain MA, eds. Rehabilitation ofthe physically disabled adult. London: Croom Helm, 1988:701-23. punctured the brakes (which work by a plate being pushed or 10 Harris A, Cox E, Smith CRW. Handicapped and impaired in Great Bnrtain. Part 1. London: HMSO, 1971. pulled against the outer edge of the tyre) are ineffective, and 11 Platts EA. Wheelchair design -survey of users' views. Proceedings ofthe Royal Society ofMedicine hence the wheelchair may move when patients get up or sit 1974;67:414-6. 12 Abel EW. Survey of attendant propelled mobile chairs used in hospitals. Health Bull (Edinb) down, causing them to fall. 1983;41:275-7. Failure ofbrakes caused by faults in the braking mechanism 13 Bossingham DH. Wheelchairs and appliances. Clinics in Rheumatic Diseases 1981;7:395-415. 14 Jay P. Choosing the best wheelchair cushion. London: Royal Association for Disability and has been shown in almost two thirds ofhospital wheelchairs in Rehabilitation, 1984. Leeds and Wessex.47 Many wheelchair brakes are crude 15 Penn ND, Belfield PW, Young JB, Whitley AJ, Mulley GP, Mascie-Taylor BH. No more flat tvres: a trial of a tyre insert for wheelchairs. Clinical Rehabilitation (in press). devices, which work loose and need constant adjustment.6 A 16 McLaurin C. Wheelchair development, standards, progress and issues. Rehabil Res Dev quarter ofwheelchair users at find to 1986;23:48-5 1. home the brakes difficult 17 Feeney RJ. Are aids for the disabled consumer goods? In: Bray J, Wright S, eds.
    [Show full text]
  • Neurasthenia at Mengo Hospital, Uganda: a Case Study in Psychiatry and a Diagnosis, 1906–50
    The Journal of Imperial and Commonwealth History ISSN: 0308-6534 (Print) 1743-9329 (Online) Journal homepage: http://www.tandfonline.com/loi/fich20 Neurasthenia at Mengo Hospital, Uganda: A case study in psychiatry and a diagnosis, 1906–50 Yolana Pringle To cite this article: Yolana Pringle (2016): Neurasthenia at Mengo Hospital, Uganda: A case study in psychiatry and a diagnosis, 1906–50, The Journal of Imperial and Commonwealth History, DOI: 10.1080/03086534.2015.1123975 To link to this article: http://dx.doi.org/10.1080/03086534.2015.1123975 © 2016 The Author(s). Published by Taylor & Francis. Published online: 11 Jan 2016. Submit your article to this journal Article views: 66 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=fich20 Download by: [University of Cambridge] Date: 27 March 2016, At: 06:16 THE JOURNAL OF IMPERIAL AND COMMONWEALTH HISTORY, 2016 http://dx.doi.org/10.1080/03086534.2015.1123975 Neurasthenia at Mengo Hospital, Uganda: A case study in psychiatry and a diagnosis, 1906–50 Yolana Pringle Centre for Research in the Arts, Social Sciences and Humanities (CRASSH), University of Cambridge, Cambridge, UK ABSTRACT KEYWORDS This article uses a case-study approach to examine the Psychiatry; empire; Uganda; complex and contradictory nature of diagnoses like neurasthenia; mission neurasthenia in colonial Africa. Drawing on the case notes medicine; detribalisation of European and African patients diagnosed with neurasthenia at the Church Missionary Society’s Mengo Hospital, Uganda, it argues that in practice, and outside the colonial asylum in particular, ideas about race and mental illness were more nuanced than histories of psychiatry and empire might imply.
    [Show full text]
  • Hypoactive Sexual Desire Disorder in Females
    Running head: FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER 1 Female Hypoactive Sexual Desire Disorder A Summary Paper Presented to The Faculty of the Adler Graduate School ___________________ In Partial Fulfillment of the Requirements for the Degree of Master of Arts in Adlerian Counseling and Psychotherapy __________________ By: Mera Le Colling October 2011 FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER 2 Abstract Hypoactive sexual desire disorder is the most prevalent sexual disorder in women, and one of the most challenging to overcome. This paper discusses the current definition for HSDD, the prevalence of HSDD in women, definitions of sexual health and sexual desire, sexual myths and HSDD, and criticisms around creating sexual norms and ideals related to HSDD. This paper will also discuss physical vs. psychological arousal in women, physical, psychological, and relational aspects of HSDD, male HSDD, an Adlerian perspective of HSDD, theories of desire, and proposed definitions of female HSDD including a proposed DSM-V revision of HSDD. Treatment options discussed include hormonal, antidepressant, herbal, CBT, and mindfulness. FEMALE HYPOACTIVE SEXUAL DESIRE DISORDER 3 Acknowledgments I would like to thank Professor Jere Truer for his guidance and encouragement in the selection of my master’s project. I would also like to thank Earl Heinrich for his ongoing assistance throughout my time at Adler Graduate School. Herb Laube, as both my master’s project reader and as my instructor in many classes, did much to mold my interest in psychology and human sexuality. I also wish to acknowledge the role my family played in my education, specifically Henrietta Truh and Lois Truh, my maternal grandmother and mother.
    [Show full text]
  • Energy, Aging, and Neurasthenia
    Andersen | 47 Energy, Aging, and Neurasthenia A Historical Perspective Michael Andersen University of Copenhagen Author contact: [email protected] Abstract That there is an association between energy and aging may seem commonsensical in modern society. Nonetheless, the question of how aging came to be associated with energy is less well known. This article explores how the 19th century disease of neurasthenia became related to aging through contemporaneous ideas about productivity, energy surplus and energy dissipation based on an analysis of how a lack of energy was featured as a symptom of the disease. It examines the specific historical intersection where a lack of energy was related to a diagnosis, illustrates how aging and energy have become intrinsically tied to each other and how the focus on the productive uses of energy has antecedents in religion as well as moral economics. As aging continues to be considered a problem in modern society--in large part due to the inherent unproductivity associated with old age caused by a lack of energy--the discourses surrounding neurasthenia demonstrate how the concept of energy manifested itself in contemporaneous consciousness. Keywords: aging; disease; neurasthenia; energy Anthropology & Aging, Vol 40, No 2 (2019), pp. 48-59 ISSN 2374-2267 (online) DOI 10.5195/aa.2019.170 This work is licensed under a Creative Commons Attribution 4.0 International License. This journal is published by the University Library System of the University of Pittsburgh as part of its D-Scribe Digital Publishing Program, and is cosponsored by the University of Pittsburgh Press. Anthropology & Aging Vol 40, No 2 (2019) ISSN 2374-2267 (online) DOI 10.5195/aa.2019.170 http://anthro-age.pitt.edu Andersen | 48 Energy, Aging, and Neurasthenia A Historical Perspective Michael Andersen University of Copenhagen Author contact: [email protected] Introduction An old story often told is that the human body is a phenomenon that inevitably ages.
    [Show full text]
  • The Interesting but Confusing Phenomenon of Neurasthenia and Chronic Fatigue Syndrome
    Update Article The interesting but confusing phenomenon of neurasthenia and chronic fatigue syndrome K Y Mak 麥基恩 Summary means ‘nerves exhaustion’, thus conveying some physical problems with the body. The term ‘neurasthenia’ is rather confusing, particularly for the Chinese. It has undergone Brown, a pupil of Cullen, developed the concept of metamorphosis, and is nowadays characterised by neurasthenia at the end of the 18th century to describe unexplained persistent physical symptoms especially general functional disorders of the nervous system with chronic fatigue. It is a common presentation to primary no specific localised lesions found. Kraus in 1831 and care doctors, and these patients are frequent consumers Most in 1836 equated neurasthenia as a synonym for of health care services of various types. There is a high nervous weakness, and von Deusen wrote about the topic association with psychological distress and other some 30 years later.1 However, it was George M Beard psychiatric disorders have to be ruled out in order to who in 1867 described more than 50 symptoms, both reduce confusion. Treatment is rather non-specific, physical and mental, that can be diagnosed as though antidepressants and/or cognitive-behavioural neurasthenia. The main feature is that of unexplained therapy can be quite effective. The author recommends 2 that the term ‘eurasthenia’ be used as a layman term while chronic ‘fatigue’ and weakness. According to him, the communicating with the patient, but to use ‘chronic disorder was the exhaustion of the nervous force caused fatigue syndrome’ as a medical terminology when by environmental factors and rapid social changes in corresponding with other colleagues.
    [Show full text]
  • The ICD-10 Classification of Mental and Behavioural Disorders
    The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines World Health Organization -1- Preface In the early 1960s, the Mental Health Programme of the World Health Organization (WHO) became actively engaged in a programme aiming to improve the diagnosis and classification of mental disorders. At that time, WHO convened a series of meetings to review knowledge, actively involving representatives of different disciplines, various schools of thought in psychiatry, and all parts of the world in the programme. It stimulated and conducted research on criteria for classification and for reliability of diagnosis, and produced and promulgated procedures for joint rating of videotaped interviews and other useful research methods. Numerous proposals to improve the classification of mental disorders resulted from the extensive consultation process, and these were used in drafting the Eighth Revision of the International Classification of Diseases (ICD-8). A glossary defining each category of mental disorder in ICD-8 was also developed. The programme activities also resulted in the establishment of a network of individuals and centres who continued to work on issues related to the improvement of psychiatric classification (1, 2). The 1970s saw further growth of interest in improving psychiatric classification worldwide. Expansion of international contacts, the undertaking of several international collaborative studies, and the availability of new treatments all contributed to this trend. Several national psychiatric bodies encouraged the development of specific criteria for classification in order to improve diagnostic reliability. In particular, the American Psychiatric Association developed and promulgated its Third Revision of the Diagnostic and Statistical Manual, which incorporated operational criteria into its classification system.
    [Show full text]
  • Postraumatic Stress Disorders (Ptsd) Between Fallacy and Facts
    Psychiatria Danubina, 2012; Vol. 24, No. 3, pp 241-245 View point article © Medicinska naklada - Zagreb, Croatia POSTRAUMATIC STRESS DISORDERS (PTSD) BETWEEN FALLACY AND FACTS: WHAT WE KNOW AND WHAT WE DON'T KNOW? Miro Jakovljević, Lovorka Brajković, Mladen Lončar & Ana Čima Department of Psychiatry, University Hospital Centre Zagreb, Croatia received: 5.6.2012; revised: 18.6.2012; accepted: 27.6.2012 SUMMARY Background: PTSD been recognized as a major problem in public health and has attracted an ever-growing scientific, epistemological and clinical interest. On the other side, PTSD is one of the most controversial diagnosis in psychiatry as well as in medicine in general. Method: We have made an overview of available literature on PTSD to identify what is our real knowledge about PTSD with all dilemmas, controversies and challenges. Results: We have various options as to how to evaluate, explain and describe PTSD and other trauma-related mental and somatic disorders. In this paper we compiled an extensive set of facts and meta-facts in order to to understand the real nature of traumatic stress, negative life events and PTSD. Conclusion: Conflict between various concepts of PTSD and our current knowledge will probably bring with itself a new scientific paradigm with new diagnostic phenotypes and refining the old ones. Key words: PTSD – concepts - facts and meta-facts * * * * * INTRODUCTION modalities, as well as what kind of compensation is owed to patients with PTSD by society (Wessely 2005, The relationship between negative life events, Benedek & Wynn 2011, Stein et al. 2011). According to psychotrauma and medical disorders has for a long time some authors „in the case of PTSD, the cart went before attracted considerable attention of mental health the horse; that the order of the things was, first, social professionals, the medical community as well as the and political; second, theoretical; and only third, emphi- media.
    [Show full text]